Skip to main content
ABINGDON HEALTH PLC logo

ABINGDON HEALTH PLC — Investor Relations & Filings

Ticker · ABDX ISIN · GB00BLF79J41 LEI · 213800XFI4WV3FBILO20 IL Manufacturing
Open in API
Filings indexed 261 across all filing types
Latest filing 2023-10-11 Report Publication Anno…
Country GB United Kingdom
Listing IL ABDX

About ABINGDON HEALTH PLC

https://www.abingdonhealth.com/

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 6893P) from Abingdon Health plc. The primary purpose of the announcement is to inform the market about the upcoming release date of the 'final results for the year ended 30 June 2023' and to schedule a subsequent 'Investor presentation' related to those results. Since the document itself is not the full financial report (10-K or IR) but rather an announcement about the publication of results and a related presentation, it fits the definition of a Report Publication Announcement (RPA). It explicitly states when the results will be issued and when the presentation will occur, which is the core function of an RPA.
2023-10-11 English
Partnership with Morrama
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 6380L' and contains standard regulatory boilerplate language at the end, including references to 'Market Abuse Regulation (EU) 596/2014' and 'Regulatory Information Service'. This strongly indicates a regulatory announcement distributed via the RNS system. The content itself is an announcement about a strategic partnership and the formation of a new company (Eco-Flo Innovations Ltd) to develop sustainable lateral flow devices. This is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A). Since it is a specific corporate action announcement distributed via RNS that doesn't fit perfectly into categories like M&A (TAR) or Capital Change (CAP), the most appropriate general category for a standard, non-financial, non-meeting related regulatory update distributed via RNS is the fallback category, Regulatory Filings (RNS). The document length (8429 chars) is substantial enough that it is the primary announcement, not just a brief notice of publication (RPA).
2023-09-07 English
Agreed changes to Concert Party
Regulatory Filings Classification · 98% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement by the header 'RNS Number : 7142K' and the concluding boilerplate text mentioning RNS and the London Stock Exchange. The content discusses changes to a shareholder 'concert party' under the City Code on Takeovers and Mergers, detailing specific shareholder groups and their percentage interests. This type of corporate action update, especially when disseminated via RNS, is a general regulatory announcement. Since it does not fit the specific definitions for Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Capital/Financing Update (CAP), and it is a direct announcement rather than a full report, the most appropriate classification is the general regulatory filing category, RNS.
2023-08-30 English
Salistick™ to be launched in Tesco
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated August 15, 2023. It announces a commercial update: Tesco rolling out the Salistick pregnancy test. The text concludes with standard disclaimers referencing 'RNS, the news service of the London Stock Exchange' and 'Market Abuse Regulation (EU) 596/2014'. This structure is characteristic of a general regulatory news service announcement, which is the definition of RNS (Regulatory Filings) when the content doesn't fit a more specific category like ER, DIV, or CAP. Since this is a general business/product update announced via the RNS system, RNS is the most appropriate classification.
2023-08-15 English
Trading Update
Earnings Release Classification · 99% confidence The document begins with 'RNS Number' and contains key financial highlights for the year ended 30 June 2023 ('FY23'), including revenue expectations and cash position updates. It provides a trading update, which is a summary of performance for a period, but it is not the full, comprehensive report (like a 10-K or IR). The presence of the RNS header and the nature of the content (trading update with highlights and outlook) strongly suggest this is an initial announcement of financial performance before the full report is released. This aligns best with the 'Earnings Release' (ER) definition, which covers initial announcements of periodical financial results (key highlights only). It is not a Call Transcript (CT), a full Interim Report (IR), or a Report Publication Announcement (RPA) because it contains the substantive results, not just an announcement that results are forthcoming. FY 2023
2023-07-06 English
Launch of Salistick™ saliva pregnancy test
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 0462D' and contains standard boilerplate language associated with regulatory news service dissemination, including references to the 'Regulatory Information Service' and the 'London Stock Exchange'. The content itself is an announcement regarding the 'Launch of Salistick™ saliva pregnancy test' and provides business updates, market context, and contact information. This structure strongly indicates a general regulatory announcement rather than a specific statutory report like a 10-K, an earnings release (ER), or a detailed interim report (IR). Since it is a general regulatory announcement distributed via RNS that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), the most appropriate classification is the general regulatory filing category.
2023-06-19 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.